W. B. Frijlink

TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)

W. B. Frijlink, OlavL.M. Bijvoet, J. te Velde et al. · The Lancet · 1979 · 258 citations

Osteopathy, Pharmacology, Experimental Therapeutic +4

Apd in paget's disease of bone role of the mononuclear phagocyte system?

O. L. M. Bijvoet, W. B. Frijlink, Kon‐Siong G. Jie et al. · Arthritis & Rheumatism · 1980 · 133 citations

Bone Disease, Rheumatology, Autoimmune Disease +13

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium

F.J.M. van Breukelen, O. L. M. Bijvoet, W. B. Frijlink et al. · Calcified Tissue International · 1982 · 68 citations

Serum Calcium, Electrolyte Disorder, Amino-hydroxypropylidene Bisphosphonate +8

Relation Between Signs and Symptoms in Paget's Disease of Bone

H.I.J. Harinck, O. L. M. Bijvoet, C.J.L.R. Vellenga et al. · QJM · 1986 · 65 citations

Bone Disease, Relation Between Signs, Frequency Distribution +14

Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—Studies of the effects of a bisphosphonate treatment

S. Adámi, W. B. Frijlink, O. L. M. Bijvoet et al. · Calcified Tissue International · 1982 · 51 citations

Health Sciences, Medicine, Physiology +7